Key Market Indicators
Sales of Korean hypnotic and sedative medicines are expected to reach US$66.46 million by 2026, up from US$58.41 million in 2021. This represents an average annual growth rate of 2.3% over the five-year period from 2021 to 2026. Since 2013, the Korean market has seen a year-on-year growth of 6.7%. In 2021, Korea came in sixth place in the world ranking, overtaken by Spain at US$58.41 million. Germany, Sweden and Belgium were the second, third and fourth largest markets respectively.